Sarcoma patients' significant symptom burden negatively impacts quality of life
the ONA take:
Adult patients with sarcoma experience a significant physiological and psychological symptom burden, which has a strong negative impact on health-related quality of life (HRQoL), with numerous physiological symptoms undertreated with medications, a study published in the journal Supportive Care in Cancer has shown.
For the study, researchers evaluated 79 patients with sarcoma in order to evaluate how symptom burden affects HRQoL and medication use. Most patients were diagnosed with stromal tumor, while some had leiomyosarcoma and liposarcoma.
Results showed that the most common physical symptoms experienced by patients were tiredness, lack of energy, and difficulty sleeping, while the most prevalent psychological symptoms were irritability, worrying, and anxiety.
Researchers found that 33.0% of patients reported difficulty sleeping, but only 6.3% of all patients received hypnotics.
Similarly, only 1.3% of all patients received appetite stimulants while 27.9% of patients reported experiencing lack of appetite.
Adult patients with sarcoma experience significant symptom burden, which has a strong negative impact on health-related quality of life.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|